Actively Recruiting
ASSESS ALL ALS Longitudinal Biomarker Study for Symptomatic and Control Participants with Amyotrophic Lateral Sclerosis
Led by St. Joseph's Hospital and Medical Center, Phoenix · Updated on 2026-08-24
2000
Participants Needed
37
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting the ALL ALS Clinical Research Consortium study to collect a wide variety of samples, clinical data, and measurements from people with symptomatic Amyotrophic Lateral Sclerosis ALS, ALS gene carriers, and control participants without ALS. This study aims to create a harmonized data and sample repository to support future ALS and related neurological disease research. The study is funded by the NIHNINDS and coordinated across multiple clinical sites nationwide. Participants include symptomatic ALS patients and controls, with some ALS participants visiting clinics onsite and others participating remotely via video conferencing and home blood collection. The study follows participants for 24 months, during which medical history, clinical outcomes, and blood samples are collected every 4 months. Participants also complete monthly patient-reported outcomes and speech recordings. Optional cerebrospinal fluid samples may be collected at onsite visits. During the study, participants undergo assessments including the ALS Functional Rating Scale-Revised ALSFRS-R, cognitive testing, vital capacity measurements, hand muscle strength evaluations, and social and environmental history surveys. These are collected at scheduled intervals over two years. Data from these evaluations will help researchers understand ALS progression and characteristics. Participants involvement includes regular visits or remote sessions, with ongoing monitoring and data collection throughout the study period.
CONDITIONS
Brief Title
ASSESS ALL ALS Study
Research Team
A
ALL ALS Patient Navigator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here